shopping cart Your cart is empty
  • Home
  • Medical Devices
  • Theranostics Market By Applications (Nero Disorders), Industry Size, Growth, Share And Forecast To 2022

Theranostics Market By Applications (Nero Disorders), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: May 5, 2016

Key Findings


The global theranostics market is expected to grow at an impressive CAGR during 2015-2022.The drivers which are growing the market are clinical features by the pharmaceutical companies, cost reduction, confined use of diagnostic experiments. The major factors driving the market is coordination between drug and diagnostics companies. For Example Amsterdam Castle and NyIncare are uplifting the research in theranostics devices and it is anticipated to further drive the growth of the theranostics market.


Market Segment Insight


The Theranostics is segmented on the basis of application. On the basis of different application the market is segmented ascancer, cardiovascular diseases and euro Disorders. According to world health organization more than 10 million cases of cancer are diagnosed every year worldwide which is becoming one of the major health concern. Therapeutic techniques with minimum side-effect and good diagnostic are highly required to treat cancer. It is recognized that theranostics imaging helps in killing cells of prostate cancer without any harm to health cell. In the current scenarios there are new inventions taking place in cancers with the help of Theranostics devices. It is estimated that in 7000drugs only five present is used to treat CSN diseases and only one percent is active in treatment of brain. The neuro disorder theranostics market is expected to increase rapidly during the forecast period. This is because of technological advancements such as trans-nasal brain drug delivery, Blood–Brain Barrier (BBB) disruption, transcranial brain drug delivery, and small molecule lipidization etc.


Regional Insight


Major regions including North America, Europe, Asia Pacific, and Rest of the World are segmented regionally in the global theranostics market. North America has the largest market share of theranostics followed by Europe. The major reason for high growth rate is presence of medical conditions such as cancer, neurological disorders, and physician awareness regarding treatment benefits. Europe market also have maximum share in the theranostics market devices as theranostics are mostly accessed by the European people and there is further need of spreading awareness regarding theranostics devices.


Competitive Insights


Some of the major market players are 23andMe, Abbott Laboratories, AmeriPath, Axis-Shield, Beckman Coulter, Becton, Dickinson & Company, BIOTEC Laboratories, BioTheranostics and Cellestisetc. Acquisition, mergers and expansions are the key strategies adopted by the market players to sustain in the market. Quest Diagnostics Incorporation acquiredAmeriPath, Inc. in a transaction valued at $2 billion 2014.

CHAP 1. METHODOLOGY & SCOPE 10
1.1. RESEARCH METHODOLOGY 10
1.2. RESEARCH SCOPE & ASSUMPTIONS 10
1.3. LIST OF DATA SOURCES 10


CHAP 2. EXECUTIVE SUMMARY 11
2.1. GLOBAL THERANOSTICS SUMMARY & KEY BUYING CRITERIA 11
2.2. GLOBAL THERANOSTICS OUTLOOK 11
2.3. MARKET SEGMENTATION ANALYSIS 11
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 11
2.5. GLOBAL THERANOSTICS VALUE CHAIN ANALYSIS 11
2.6. VENDOR LANDSCAPE 11


CHAP 3. GLOBAL THERANOSTICS MARKET DETERMINENTS 12
3.1. MARKET DRIVER ANALYSIS 12
3.2. MARKET RESTRAINT ANALYSIS 12
3.3. KEY OPPORTUNITIES 12
3.4. CHALLENGES 12


CHAP 4. INDUSTRY ANALYSIS 13
4.1. GLOBAL THERANOSTICS – PORTER’S FIVE FORCE MODEL 13
4.2. GLOBAL THERANOSTICS – PESTEL ANALYSIS 13
4.3. GLOBAL THERANOSTICS – GAP ANALYSIS 13


CHAP 5. GLOBAL THERANOSTICS MARKET BY APPLICATIONS , 2012-2022 ($ BILLION) 14
5.1. GLOBAL THERANOSTICS MARKET BY NERO DISORDERS 2012-2022(BILLIONS) 14


CHAP 6. GLOBAL THERANOSTICS MARKET , REGIONAL OUTLOOK 2012-2022 ($ BILLION) 16
6.1. GLOBAL THERANOSTICS BY REGION 2012-2022 ($ BILLION) 16
6.2. NORTH AMERICA 16
6.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 16
6.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 16
6.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 16
6.2.3.1. U.S. 16
6.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 16
6.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 16
6.2.3.2. CANADA 16
6.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 16
6.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 16
6.3. EUROPE 16
6.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 16
6.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 16
6.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 16
6.3.3.1. GERMANY 16
6.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 17
6.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 17
6.3.3.2. UK 17
6.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 17
6.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 17
6.3.3.3. FRANCE 17
6.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 17
6.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 17
6.3.3.4. SPAIN 17
6.3.3.4.1. SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 17
6.3.3.4.2. SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 17
6.3.3.5. REST OF EUROPE 17
6.3.3.5.1. RUSSIA MARKET ESTIMATES AND FORECAST2012-2022($BILLION) 18
6.3.3.5.2. OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 18
6.4. ASIA PACIFIC 18
6.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 18
6.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 18
6.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 18
6.4.3.1. CHINA 18
6.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 18
6.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 18
6.4.3.2. INDIA 18
6.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 18
6.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 18
6.4.3.3. JAPAN 18
6.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 18
6.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION) 18
6.4.3.4. OTHERS 18
6.4.3.4.1. OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($BILLION) 19
6.4.3.4.2. OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 19
6.5. MIDDLE EAST & AFRICA 19
6.5.1. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
6.5.2. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
6.6. LATIN AMERICA 19
6.6.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
6.6.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
6.6.2.1. BRAZIL 19
6.6.2.1.1. BRAZIL MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
6.6.2.1.2. BRAZIL MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19


CHAP 7. COMPETITIVE LANDSCAPE 20
7.1. 23ANDME 21
7.1.1. COMPANY OVERVIEW 21
7.1.2. SCOT ANALYSIS 21
7.1.3. PRODUCT BENCHMARKING 21
7.1.4. STRATEGIC INITIATIVES 21
7.2. ABBOTT LABORATORIES 21
7.2.1. COMPANY OVERVIEW 21
7.2.2. SCOT ANALYSIS 21
7.2.3. PRODUCT BENCHMARKING 21
7.2.4. STRATEGIC INITIATIVES 21
7.3. AMERIPATH 21
7.3.1. COMPANY OVERVIEW 21
7.3.2. SCOT ANALYSIS 21
7.3.3. PRODUCT BENCHMARKING 21
7.3.4. STRATEGIC INITIATIVES 21
7.4. AXIS-SHIELD 21
7.4.1. COMPANY OVERVIEW 21
7.4.2. SCOT ANALYSIS 21
7.4.3. PRODUCT BENCHMARKING 21
7.4.4. STRATEGIC INITIATIVES 21
7.5. BECKMAN COULTER 21
7.5.1. COMPANY OVERVIEW 21
7.5.2. SCOT ANALYSIS 21
7.5.3. PRODUCT BENCHMARKING 21
7.5.4. STRATEGIC INITIATIVES 21
7.6. BECTON 21
7.6.1. COMPANY OVERVIEW 21
7.6.2. SCOT ANALYSIS 22
7.6.3. PRODUCT BENCHMARKING 22
7.6.4. STRATEGIC INITIATIVES 22
7.7. DICKINSON & COMPANY 22
7.7.1. COMPANY OVERVIEW 22
7.7.2. SCOT ANALYSIS 22
7.7.3. PRODUCT BENCHMARKING 22
7.7.4. STRATEGIC INITIATIVES 22
7.8. BIOTEC LABORATORIES 22
7.8.1. COMPANY OVERVIEW 22
7.8.2. SCOT ANALYSIS 22
7.8.3. PRODUCT BENCHMARKING 22
7.8.4. STRATEGIC INITIATIVES 22
7.9. BIOTHERANOSTICS 22
7.9.1. COMPANY OVERVIEW 22
7.9.2. SCOT ANALYSIS 22
7.9.3. PRODUCT BENCHMARKING 22
7.9.4. STRATEGIC INITIATIVES 22
7.10. CELLESTIS 22
7.10.1. COMPANY OVERVIEW 22
7.10.2. SCOT ANALYSIS 22
7.10.3. PRODUCT BENCHMARKING 22
7.10.4. STRATEGIC INITIATIVES 22
7.11. CENTER FOR DISEASE CONTROL AND PREVENTION 22
7.11.1. COMPANY OVERVIEW 22
7.11.2. SCOT ANALYSIS 22
7.11.3. PRODUCT BENCHMARKING 22
7.11.4. STRATEGIC INITIATIVES 23
7.12. DADE BEHRING 23
7.12.1. COMPANY OVERVIEW 23
7.12.2. SCOT ANALYSIS 23
7.12.3. PRODUCT BENCHMARKING 23
7.12.4. STRATEGIC INITIATIVES 23
7.13. DIANON SYSTEMS 23
7.13.1. COMPANY OVERVIEW 23
7.13.2. SCOT ANALYSIS 23
7.13.3. PRODUCT BENCHMARKING 23
7.13.4. STRATEGIC INITIATIVES 23
7.14. DUKE UNIVERSITY 23
7.14.1. COMPANY OVERVIEW 23
7.14.2. SCOT ANALYSIS 23
7.14.3. PRODUCT BENCHMARKING 23
7.14.4. STRATEGIC INITIATIVES 23
7.15. DYNACARE LABORATORIES 23
7.15.1. COMPANY OVERVIEW 23
7.15.2. SCOT ANALYSIS 23
7.15.3. PRODUCT BENCHMARKING 23
7.15.4. STRATEGIC INITIATIVES 23

TABLE 1 GLOBAL THERANOSTICS MARKET BY APPLICATIONS , 2012-2022 ($ BILLION) 24
TABLE 2 GLOBAL THERANOSTICS MARKET BY NERO DISORDERS, 2012-2022 ($ BILLION) 24
TABLE 3 GLOBAL THERANOSTICS MARKET BY CANCERS, 2012-2022 ($ BILLION) 24
TABLE 4 GLOBAL THERANOSTICS MARKET BY CARDIOVACULAR DISEASES, 2012-2022 ($ BILLION) 24
TABLE 5 NORTH AMERICA THERANOSTICS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 24
TABLE 6 NORTH AMERICA THERANOSTICS MARKET ESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 24
TABLE 7 NORTH AMERICA THERANOSTICS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 24
TABLE 8 U.S. THERANOSTICS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 24
TABLE 9 U.S. THERANOSTICS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 24
TABLE 10 CANADA THERANOSTICS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 24
TABLE 11 CANADA THERANOSTICS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 –2022 ($ BILLION) 24
TABLE 12 CANADA THERANOSTICS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 24
TABLE 13 EUROPE THERANOSTICS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 24
TABLE 14 EUROPE THERANOSTICS MARKET ESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 24
TABLE 15 EUROPE THERANOSTICS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 25
TABLE 16 GERMANY THERANOSTICS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 25
TABLE 17 THERANOSTICS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 25
TABLE 18 UK THERANOSTICS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 25
TABLE 19 UK THERANOSTICS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 25
TABLE 20 ASIA PACIFIC THERANOSTICS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 25
TABLE 21 ASIA PACIFIC THERANOSTICS MARKET ESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 25
TABLE 22 ASIA PACIFIC THERANOSTICS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 25
TABLE 23 CHINA THERANOSTICS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 25
TABLE 24 CHINA THERANOSTICS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 25
TABLE 25 INDIA THERANOSTICS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 25
TABLE 26 INDIA THERANOSTICS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 25
TABLE 27 JAPAN THERANOSTICS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 25
TABLE 28 JAPAN THERANOSTICS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 25
TABLE 29 MIDDLE EAST & AFRICA THERANOSTICS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 25
TABLE 30 MIDDLE EAST & AFRICA THERANOSTICS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 25
TABLE 31 CENTRAL & SOUTH AMERICA THERANOSTICS MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 25
TABLE 32 CENTRAL & SOUTH AMERICA THERANOSTICS MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION 26

FIGURE 1 MARKET SHARE BY REGIONS 26
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 26
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 26
FIGURE 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 26
FIGURE 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 26
FIGURE 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 26
FIGURE 7 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 26
FIGURE 8 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 26
FIGURE 9 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 26
FIGURE 10 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 26
FIGURE 11 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 26
FIGURE 12 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 26
FIGURE 13 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 27

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)